Hongxing Corp.(001209)
Search documents
1月29日晚间重要公告一览
Xi Niu Cai Jing· 2026-01-29 10:13
Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]
洪兴股份(001209.SZ):预计2025年净利润同比下降73.84%-78.82%
Ge Long Hui A P P· 2026-01-29 08:39
Core Viewpoint - Hongxing Co., Ltd. (001209.SZ) expects a significant decline in net profit for 2025, projecting a range of 17 million to 21 million yuan, which represents a decrease of 73.84% to 78.82% compared to the same period last year [1] Financial Performance - The net profit attributable to shareholders is forecasted to be between 17 million and 21 million yuan, indicating a substantial year-on-year decline [1] - The net profit after deducting non-recurring gains and losses is estimated to be between 8.5 million and 12.5 million yuan, reflecting a decrease of 69.06% to 78.96% year-on-year [1] Industry Context - The industry is experiencing intense competition, which has led to a decline in the company's overall sales gross margin [1] - The performance of offline channel business has not met expectations, contributing to the financial outlook [1] - The company has completed construction projects that are now being depreciated, impacting financial results [1]
洪兴股份:2025年全年净利润同比预减73.84%—78.82%
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-29 08:22
Core Viewpoint - Hongxing Co., Ltd. is expected to report a significant decline in net profit for the year 2025, with projections indicating a decrease of 73.84% to 78.82% compared to the previous year [1] Financial Performance - The estimated net profit attributable to shareholders for 2025 is projected to be between 17 million and 21 million yuan [1] - The estimated net profit excluding non-recurring items is projected to be between 8.5 million and 12.5 million yuan, reflecting a year-on-year decrease of 69.06% to 78.96% [1] Reasons for Performance Change - The absence of insurance compensation received in the previous year amounting to 46.5 million yuan, classified as non-recurring income, is a primary factor for the profit decline [1] - Increased industry competition has led to a decrease in the company's overall sales gross margin and underperformance in offline channel business [1] - The completion of construction projects has resulted in the commencement of depreciation charges [1]
洪兴股份(001209) - 2025 Q4 - 年度业绩预告
2026-01-29 08:15
证券代码:001209 证券简称:洪兴股份 公告编号:2026-003 | 项 | 目 | | 本报告期 | | 上年同期 | | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | | 盈利:1,700 | 万元–2,100 | 万元 | 盈利:8,027.43 | 万元 | | | | | 比上年同期下降:73.84% | -78.82% | | | | 扣除非经常性损 益后的净利润 | | 盈利:850 | 万元–1,250 | 万元 | 盈利:4,039.52 | 万元 | | | | | 比上年同期下降:69.06% | -78.96% | | | | 基本每股收益 | | 盈利:0.13 | 元/股–0.16 | 元/股 | 盈利:0.62 元/股 | | 2、预计的业绩: ð 扭亏为盈 ð 同向上升 √同向下降 二、与会计师事务所沟通情况 本次业绩预告未与会计师事务所进行预沟通,未经注册会计师预审计。 三、业绩变动原因说明 广东洪兴实业股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确 ...
洪兴股份实控人方拟减持 2021上市即巅峰申万宏源保荐


Zhong Guo Jing Ji Wang· 2026-01-22 03:12
Core Viewpoint - Hongxing Co., Ltd. announced a share reduction plan involving major shareholders and senior management due to personal funding needs, which may impact the company's stock performance in the near term [1][2][3] Shareholder Reduction Plans - Major shareholders Zhou Dema, Ke Guomin, Guo Jingxuan, and their associates plan to reduce their holdings by up to 1,277,000 shares, representing 0.99% of the total share capital, between February 12 and May 11, 2026 [1] - The estimated total amount from this reduction is approximately 27.33 million yuan based on the last trading price of 21.40 yuan per share [1] - Senior management members Liu Genxiang and Cheng Shengxiang also plan to reduce their holdings by 31,960 shares (0.02%) and 47,348 shares (0.04%) respectively during the same period, with total estimated proceeds of about 1.70 million yuan [2] Current Shareholding Structure - As of the announcement date, major shareholders hold a total of 52,610,577 shares, accounting for 40.91% of the total share capital [1] - Liu Genxiang holds 127,840 shares (0.10%) and Cheng Shengxiang holds 189,392 shares (0.15%) [3] Financial Performance - For the first three quarters of 2025, the company reported revenue of 1.229 billion yuan, a year-on-year increase of 6.13%, but a significant net profit decline of 76.05% to 17.22 million yuan [3] - In 2024, the company achieved revenue of 1.775 billion yuan, an 11.18% increase, but net profit decreased by 7.88% to 80.27 million yuan [3] Company Background - Hongxing Co., Ltd. was listed on the Shenzhen Stock Exchange on July 23, 2021, with an initial public offering of 23.4865 million shares at a price of 29.88 yuan per share [4] - The total funds raised amounted to 702 million yuan, with a net amount of 641 million yuan after expenses, allocated for various projects including production and logistics [5]
1月22日重要公告一览
Xi Niu Cai Jing· 2026-01-22 02:39
Group 1: Profit Forecasts - Gan Li Pharmaceutical expects a net profit of 1.1 billion to 1.2 billion yuan for 2025, an increase of 78.96% to 95.23% year-on-year [1] - Astone Technology anticipates a net loss of 40 million to 60 million yuan for 2025, compared to a loss of 25.34 million yuan in the previous year [2] - JinkoSolar forecasts a net loss of 5.9 billion to 6.9 billion yuan for 2025 [6] - Time Space Technology expects a net loss of 235 million to 290 million yuan for 2025 [7] - Phi Li Hua predicts a net profit of 412 million to 472 million yuan for 2025, a year-on-year increase of 31.12% to 50.22% [8] - Southern Precision expects a net profit of 300 million to 370 million yuan for 2025, representing a growth of 1130% to 1417% [10] - Daikin Heavy Industries anticipates a net profit of 1.05 billion to 1.2 billion yuan for 2025, an increase of 121.58% to 153.23% [11] - Qianfang Technology expects a net profit of 250 million to 320 million yuan for 2025, recovering from a loss of 1.193 billion yuan in the previous year [18] - Bohai Leasing forecasts a net loss of 250 million to 500 million yuan for 2025, with a significant goodwill impairment loss expected [13] - Qujiang Cultural Tourism anticipates a net loss of 130 million to 165 million yuan for 2025 [31] Group 2: Corporate Announcements - Hualan Biological Engineering received approval for clinical trials of its recombinant shingles vaccine [3] - Baishan Nonferrous Metals announced the resignation of its chairman, Wang Pugong, due to work changes [4] - Binhai Energy plans to invest approximately 548 million yuan in two projects related to porous carbon and silicon-carbon anode materials [15] - Nankai Group signed a 296 million yuan equipment sales contract with Inner Mongolia Xijin Mining Co., Ltd. [16] - Tianhua New Energy is planning to issue H-shares and list on the Hong Kong Stock Exchange [12] - Xinneng Technology is also planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [28] - Lu Wei Optoelectronics intends to raise no more than 1.38 billion yuan through a private placement [26]
洪兴股份跌2.94%,成交额1389.27万元
Xin Lang Zheng Quan· 2026-01-22 01:40
Group 1 - The core point of the article highlights the recent stock performance of Hongxing Co., which has seen a decline of 2.94% in intraday trading, with a current price of 20.77 CNY per share and a market capitalization of 2.732 billion CNY [1] - As of January 22, 2025, Hongxing Co. has experienced a year-to-date stock price decrease of 0.43%, an 8.18% drop over the last five trading days, a 0.44% increase over the last 20 days, and a 7.34% increase over the last 60 days [1] - The company, established on May 20, 2004, and listed on July 23, 2021, specializes in the research, design, production, and sales of home apparel, with its main revenue sources being home clothing (49.76%), underwear (37.47%), fabrics (6.19%), accessories (3.65%), and others (2.94%) [1] Group 2 - As of September 30, 2025, Hongxing Co. reported a total revenue of 1.229 billion CNY, reflecting a year-on-year growth of 6.13%, while the net profit attributable to shareholders decreased by 76.05% to 17.22 million CNY [1] - The company has distributed a total of 138 million CNY in dividends since its A-share listing, with 91.19 million CNY distributed over the past three years [2] - As of September 30, 2025, the number of shareholders increased by 35.52% to 16,700, while the average circulating shares per person decreased by 26.21% to 5,758 shares [1]
洪兴股份:控股股东及其一致行动人拟减持不超127.7万股
Zheng Quan Shi Bao Wang· 2026-01-21 14:23
人民财讯1月21日电,洪兴股份(001209)1月21日公告,持股40.91%的控股股东、实控人周德茂、柯 国民、郭静璇及其一致行动人汕头润盈、汕头周密计划以集中竞价方式减持公司股份不超过127.7万股 (占剔除公司回购专用账户中的股份数量后总股本比例0.99%)。 ...
1月21日增减持汇总:奥泰生物增持 蓝箭电子等21股减持(表)





Xin Lang Cai Jing· 2026-01-21 13:55
Summary of Key Points Core Viewpoint - On January 21, a total of 21 A-share listed companies disclosed their shareholding changes, with notable buybacks and reductions in shareholdings by various stakeholders [1][3]. Group 1: Buyback Information - Aotai Biological plans to repurchase company shares worth between 100 million to 200 million yuan [2][4]. Group 2: Shareholding Reductions - Shenzhan Optoelectronics: Shareholder Songbao Investment intends to reduce holdings by no more than 1% [2][4]. - Hengshuai Co., Ltd.: Actual controller Yu Guomei and associated parties plan to reduce holdings by no more than 2.83% [2][4]. - Weining Health: Senior management member Wang Li plans to reduce holdings by no more than 0.0128% [2][4]. - Deepwater Haina: Shareholder Li Qin and associated parties plan to reduce holdings by no more than 1.92% [2][4]. - Xiangyuan New Materials: Shareholders Hubei Gaotou and Liangke Gaotou plan to reduce holdings by no more than 1.68% [2][4]. - Hongxing Co., Ltd.: Executives Liu Genxiang and Cheng Shengxiang plan to reduce holdings by no more than 0.06% [2][4]. - Kalait: Controlling shareholders plan to reduce holdings by no more than 3% [2][4]. - Glinda: Shareholder Juhe Investment plans to reduce holdings by no more than 3% [2][4]. - Fushi Holdings: Directors and executives plan to reduce holdings by no more than 0.04% [2][4]. - Xinxinda: Shareholders plan to reduce holdings by no more than 3% [2][4]. - Dongjian Technology: Shareholder and director Ma Huiyang plans to reduce holdings by no more than 2.56% [2][4]. - Yayi Technology: Shareholder Qinyi Partnership plans to reduce holdings by no more than 0.1846% [2][4]. - Jingrui Electric Materials: Controlling shareholder Xinyin International plans to reduce holdings by no more than 2% [2][4]. - Xueqi Electric: Shareholder Zhi Dao Investment plans to reduce holdings by no more than 3% [2][4]. - Blue Arrow Electronics: Shareholder Yin Shengyu reduced holdings by 2.3995 million shares from January 16 to January 20 [2][4]. - Wentai Technology: Zhuhai Ronglin and associated parties plan to reduce holdings [2][4]. - Tianwang Electric: Controlling shareholders plan to reduce holdings by no more than 1.09% [2][4]. - Beifang Navigation: Chairman Li Haitao plans to reduce holdings by no more than 31,100 shares [2][4]. - Huada New Materials: Shareholders plan to reduce holdings by no more than 1.46% [2][4]. - Yong'an Futures: Shareholder Zhejiang Dongfang plans to reduce holdings by no more than 3% [2][4]. - Xinjie Electric: Senior management member Guo Zhiqiang plans to reduce holdings by no more than 0.41% [2][4].
洪兴股份(001209.SZ):控股股东、实际控制人及其一致行动人拟减持不超过0.99%股份
Ge Long Hui A P P· 2026-01-21 11:49
格隆汇1月21日丨洪兴股份(001209.SZ)公布,合计持有公司股份52,610,577股(占剔除公司回购专用账 户中的股份数量后总股本比例40.91%)的控股股东、实际控制人周德茂、柯国民、郭静璇及其一致行 动人汕头润盈、汕头周密拟在本减持计划公告之日起15个交易日后的3个月内(2026年2月12日至2026年 5月11日)以集中竞价方式减持公司股份不超过1,277,000股(占剔除公司回购专用账户中的股份数量后 总股本比例0.99%)。 ...